These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10941138

  • 1. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
    Bando K, Naganuma T, Taguchi K, Ginoza Y, Tanaka Y, Koike K, Takatoku K.
    Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acetylcholine binding site in the vesicular acetylcholine transporter.
    Ojeda AM, Kolmakova NG, Parsons SM.
    Biochemistry; 2004 Sep 07; 43(35):11163-74. PubMed ID: 15366926
    [Abstract] [Full Text] [Related]

  • 5. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
    Varoqui H, Erickson JD.
    J Physiol Paris; 1998 Apr 07; 92(2):141-4. PubMed ID: 9782458
    [Abstract] [Full Text] [Related]

  • 6. Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: synthesis and biological evaluation.
    Efange SM, Khare AB, Mach RH, Parsons SM.
    J Med Chem; 1999 Jul 29; 42(15):2862-9. PubMed ID: 10425095
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.
    Shiba K, Ogawa K, Ishiwata K, Yajima K, Mori H.
    Bioorg Med Chem; 2006 Apr 15; 14(8):2620-6. PubMed ID: 16434200
    [Abstract] [Full Text] [Related]

  • 10. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
    Jung YW, Frey KA, Mulholland GK, del Rosario R, Sherman PS, Raffel DM, Van Dort ME, Kuhl DE, Gildersleeve DL, Wieland DM.
    J Med Chem; 1996 Aug 16; 39(17):3331-42. PubMed ID: 8765517
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of radiolabeled piperazine derivatives of vesamicol as SPECT agents for cholinergic neurons.
    Bando K, Taguchi K, Ginoza Y, Naganuma T, Tanaka Y, Koike K, Takatoku K.
    Nucl Med Biol; 2001 Apr 16; 28(3):251-60. PubMed ID: 11323234
    [Abstract] [Full Text] [Related]

  • 12. Vesamicol and some of its derivatives: questionable ligands for selectively labelling acetylcholine transporters in rat brain.
    Custers FG, Leysen JE, Stoof JC, Herscheid JD.
    Eur J Pharmacol; 1997 Nov 05; 338(2):177-83. PubMed ID: 9456000
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM).
    Efange SM, von Hohenberg K, Khare AB, Tu Z, Mach RH, Parsons SM.
    Nucl Med Biol; 2000 Nov 05; 27(8):749-55. PubMed ID: 11150707
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB.
    J Med Chem; 2003 Mar 13; 46(6):925-35. PubMed ID: 12620070
    [Abstract] [Full Text] [Related]

  • 15. [3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
    Altar CA, Marien MR.
    Synapse; 1988 Mar 13; 2(5):486-93. PubMed ID: 2973145
    [Abstract] [Full Text] [Related]

  • 16. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter.
    Prior C, Marshall IG, Parsons SM.
    Gen Pharmacol; 1992 Nov 13; 23(6):1017-22. PubMed ID: 1487110
    [Abstract] [Full Text] [Related]

  • 17. Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats.
    Tsao HH, Lin KJ, Juang JH, Skovronsky DM, Yen TC, Wey SP, Kung MP.
    Nucl Med Biol; 2010 May 13; 37(4):413-9. PubMed ID: 20447551
    [Abstract] [Full Text] [Related]

  • 18. Kinetic parameters for the vesicular acetylcholine transporter: two protons are exchanged for one acetylcholine.
    Nguyen ML, Cox GD, Parsons SM.
    Biochemistry; 1998 Sep 22; 37(38):13400-10. PubMed ID: 9748347
    [Abstract] [Full Text] [Related]

  • 19. Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain.
    Choi SR, Hou C, Oya S, Mu M, Kung MP, Siciliano M, Acton PD, Kung HF.
    Synapse; 2000 Dec 15; 38(4):403-12. PubMed ID: 11044887
    [Abstract] [Full Text] [Related]

  • 20. Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter.
    Wenzel B, Sorger D, Heinitz K, Scheunemann M, Schliebs R, Steinbach J, Sabri O.
    Eur J Med Chem; 2005 Dec 15; 40(12):1197-205. PubMed ID: 16095762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.